Superbugs & You

CIDRAP
  • 4.8 (21)
  • CIENCIA
Superbugs & You

CIDRAP-ASP currently produces two distinct podcast series (Superbugs and You, and Stewardship Spotlight), which focus on a multitude of issues relevant to antimicrobial resistance through interviews with content area experts. CIDRAP-ASP also hosts multiple live webinars each year, which provide an interactive opportunity for viewers to engage with our expert speakers. 

  1. 16/04/2024

    From Farm to Label: Antimicrobials and One Health

    One Health is a concept that recognizes this interconnection and emphasizes the need for collaborative approaches to solving the issue of antimicrobial resistance at all levels -  humans, animals, and the environment is undeniable. Guests on this episode include Lance Price, (George Washington University), Francisco Diez-Gonzales (University of Georgia), and Paul Plummer (Iowa State University, NIAMRRE).

  2. 09/04/2024

    Finding a Second Wind: Cystic Fibrosis

    Antimicrobials are the cornerstone of modern medicine, and this is especially true for patients with cystic fibrosis. People with CF rely on antibiotics for recurring and persistent infections, and with regular use, antibiotics become less and less effective in fighting these infections. Guests include Ella Balasa, (Patient Advocate), Helen Boucher, MD (Tufts Medicine), and Mary Booth Dwight (Cystic Fibrosis Foundation).

  3. 02/04/2024

    Arrivederci AMR: Italy and the G7 Presidency

    Season 4 of Superbugs and You is here! Episode 14: This year, Italy leads the Presidency of the G7. The group is united by common values in addressing global challenges, including antimicrobial resistance. This episode features Italian leaders driving transformational policy to battle AMR. Guests include Francesca Chiara, (CIDRAP ASP), Mariano Votta (Active Citizenship Network-Cittadinanzattiva), Damiano De Felice (CARB-X), and Massimo Sartelli (Global Alliance for Infections in Surgery).

  4. 26/03/2024

    Oh, $@%!: Drug-resistant Shigella

    Health officials around the world are sounding the alarm on a highly infectious bacteria causing extensively drug-resistant infections. Shigella, which causes the infection known as shigellosis, is a genus of bacteria that results in gastrointestinal distress that ranges from uncomfortable to deadly, in adults and children. Global surveillance efforts on Shigella have identified outbreaks of strains that are extensively drug-resistant across the UK, US, and parts of Europe. How is the world dealing with this new superbug?   Guests Lou Bourgeois, PhD: Johns Hopkins, Science Officer for Enteric and Diarrheal Diseases, PATH Gauri Godbole, MBBS, MD: UKHSA, Consultant Microbiologist and Parasitologist, Hospital for Tropical Diseases, University College London Hospitals, NHS Naemah Logan, MD: Medical Officer, Surveillance Epidemiologist, National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), Centers for Disease Control and Prevention (CDC) Louise Francois Watkins, MD: Medical Officer, NARMS, Centers for Disease Control and Prevention: CDC

  5. 14/03/2023

    Fighting for the Future: Neonatal Sepsis

    Despite great improvements in mortality for children under 5, sepsis remains a leading cause of death in young children. The highest incidence and mortality were seen in newborns, with the biggest impact seen in low- and middle-income countries in sub-Saharan Africa and Asia. This episode will highlight how the availability of guidelines, diagnostics, and therapeutics can make a difference in the smallest of patients. Content warning: this episode contains discussions of infant loss. Guests: Kamala Thiagarajan - Freelance journalist, Global health and environmental sciences Seamus O’Brien - Director of Research and Development, Global Antibiotic Research and Development Program Phoebe Williams - Pediatrician, Infectious Disease Physician, Faculty of Medicine,  University of Sydney Materials Mentioned in this Episode Neonatal sepsis: the new threat posed by superbugs, Kamala Thiagarajan, BBC Antibiotics needed to treat multidrug-resistant infections in neonates, Phoebe Williams, …, Seamus O’Brien et al., Bulletin of the World Health Organization

  6. 07/03/2023

    Fungus Among Us: Resistant Candida auris

    Around the world, the multidrug resistant and pan-resistantfungus Candida auris has caused outbreaks in healthcare systems. While it is now highlighted by CDC as an urgent threat, only six years ago there were no reports of resistant C. auris strains that were able to spread easily between patients. These infections are challenging to treat a with 5% — 10% of colonized patients going on to develop invasive infections. This episode will cover how these outbreaks have impacted patients, healthcare systems, and continued efforts to better understand and slow the impact of these infections. Guests: Tom M Chiller - Chief, Mycotic Diseases Branch, Centers for Disease Control and Prevention Andrew Jacobs - Reporter, Health and Science desk, The New York Times Bhavarth Shukla - Associate Professor, Division of Infectious Diseases, University of Miami Materials Mentioned in this Episode A Mysterious Infection, Spanning the Globe in a Climate of Secrecy, Matt Richtel and Andrew Jacobs, The New York Times 2022 Special Report: COVID-19 U.S. Impact on Antimicrobial Resistance, Centers for Disease Control and Prevention

  7. 28/02/2023

    Phage Against the Routine: Resistant Acinetobacter

    Defined as ​an “urgent” AMR threat by the US CDC, resistant Acinetobacter baumanii cause deadly infections and are difficult to remove from the environment. Acinetobacter is resistant to many antibiotics and is a frequent cause of hospital acquired infections. In the 2022 Lancet publication on drug-resistant infections (GRAM report), it was identified as the leading pathogen causing mortality in Southeast Asia. This episode will cover how infections caused by resistant Acinetobacter impact patients and on how new treatments are making an impact. Guests: Steffanie Strathdee - Associate Dean of Global Health Sciences, University of California San Diego School of Medicine; Author, The Perfect Predator Greg Merril - CEO, Adaptive Phage Therapeutics Patrick McGann - Deputy Director, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN) Jason Bennett - Director, MRSN; Associate Professor of Medicine, Walter Reed Army Institute of Research

  8. 17/02/2023

    Bonus Episode: Fungal Disease Awareness Week

    Join us for a sneak peak of Season 3 of Superbugs and You by listening to a portion of our interview with Dr. Tom Chiller, Chief of the Mycotic Diseases Branch at the Centers for Disease Control and Prevention, discussing Candida auris.

Ver todo (16)

4.8
de 5
21 calificaciones

Acerca de

CIDRAP-ASP currently produces two distinct podcast series (Superbugs and You, and Stewardship Spotlight), which focus on a multitude of issues relevant to antimicrobial resistance through interviews with content area experts. CIDRAP-ASP also hosts multiple live webinars each year, which provide an interactive opportunity for viewers to engage with our expert speakers. 

Información

  • Creador
    CIDRAP
  • Años de actividad
    2020 - 2024
  • Episodios
    16
  • Clasificación
    Apto
  • Mostrar sitio web
    Superbugs & You

También te podría interesar

Para escuchar episodios explícitos, inicia sesión.

Mantente al día con este programa

Inicia sesión o regístrate para seguir programas, guardar episodios y enterarte de las últimas novedades.
Elige un país o región

Africa, Oriente Medio e India

Asia-Pacífico

Europa

Latinoamérica y el Caribe

Estados Unidos y Canadá